What is the VYNE stock price prediction for next 2 weeks?

According to our price prediction algorithm,VYNE Therapeutics Inc. (VYNE) price will be around $0.73 in the next 2 weeks. This means it will increase by 42.98624754420432 from the last closing price. This prediction may vary from other time period filters for VYNE stock.

What can be the highest Possible price of VYNE stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, VYNE can achieve the highest price of $0.81 which is 59.16284745558098 higher than last closing price. This prediction may vary from other time period filters for VYNE stock.

What can be the lowest Possible price of VYNE stock in next 2 weeks?

As per the forecast and algorithmic analysis, VYNE stock price can be as low as $0.65 which is 27.207717366752938 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for VYNE stock.

Will VYNE stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that VYNE stock will gain42.98624754420432 in the next 2 weeks. This prediction may vary from other time period filters for VYNE stock.

What is VYNE stock last closing price?

Last closing price of VYNE stock was $28.56.

What is VYNE stock price prediction?

VYNE stock price prediction means predicting the future closing prices of VYNE stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of VYNE stock in a certain time period.

How we predict VYNE stock future prices?

If you are searching for VYNE stock forecast, analysis or price prediction, then you might be wondering what VYNE Therapeutics Inc. (VYNE) will do in the future. Our VYNE price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This VYNE price prediction will likely answer most of your questions.

How frequent we update VYNE stock predictions?

We are updating the forecasts for the VYNE stock on daily basis.

Is using ML forecasting for VYNE stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for VYNE stock same for all the time periods?

No, the prediction for VYNE stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

VYNE Therapeutics Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$28.56-13.18%Since 2 Weeks

Predicted Price$0.7342.99%For 2 Weeks

Upper Predicted Price$0.8159.16%For 2 Weeks

Lower Predicted Price$0.6527.21%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of VYNE will rise by +42.99% over the next 2 Weeks and hit $0.73 by Friday, August 7, 2026. In that time frame, VYNE's share price is expected to range between $0.65 and $0.81.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Aug 7, 2026	0.78	0.81	0.85
Aug 6, 2026	0.78	0.81	0.84
Aug 5, 2026	0.76	0.79	0.81
Aug 4, 2026	0.74	0.76	0.79
Aug 3, 2026	0.70	0.72	0.74
Jul 31, 2026	0.64	0.66	0.68
Jul 30, 2026	0.64	0.66	0.68
Jul 29, 2026	0.62	0.63	0.65
Jul 28, 2026	0.60	0.61	0.63
Jul 27, 2026	0.56	0.57	0.59

VYNE shares rose +12.22% in Monday, July 27, 2026's trading session, rising from a previous close of $25.45 to move at $28.56. The stock demonstrated notable intraday movement (see VYNE's key stats for a full breakdown), fluctuating between $23.37 and $28.72, a +22.89% trading range. While recent weeks have seen some volatility, VYNE has managed to secure a -19.66% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 93.26K shares changing hands, 37.99K more than the previous session. This amounted to $2.66M in total market activity.

Will VYNE Continue Its Downward Trend?

According to analyst ratings and projections for VYNE, VYNE Therapeutics Inc. shares are anticipated to decrease by -3,278.57%, potentially reaching $0.85 per share by August 7, 2026. Short-term technical indicators for VYNE currently suggest a bullish sentiment. This aligns with the stock's recent performance, as it has recorded 18 positive trading days within the past 30 sessions. Based on the VYNE stock forecast, now is not the best time to buy VYNE stock because its current trading price is +3,416.81% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on VYNE covering social and institutional perspectives.

VYNE Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into VYNE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 36.56% to 41.76%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 46.13%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.13%, maintains a neutral outlook for the long term. Insights into VYNE's shareholder base show how institutional investors are positioning themselves during these momentum shifts

VYNE Therapeutics Short-Term Forecasts

VYNE Forecast For Next 5 Days

Our algorithm anticipates VYNE Therapeutics (VYNE) stock could hit $0.49 by Aug 03, 2026. This represents a -98.27% rise from today's price, following a +2.48% change over the past five days.

VYNE Forecast For Next 30 Days

Based on analysis of market trends, the outlook for VYNE Therapeutics Inc. (VYNE) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.51, which would mean a -98.21% decrease from the current price of $28.56. Projections for this period range from a high of $0.66 to a low of $0.41.

VYNE Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for VYNE Therapeutics's price over the next three months point to a drop. VYNE stock is expected to peak at $2.37 on Oct 12, 2026 after potentially dipping to $1.40 on Sep 10, 2026. On average, VYNE is likely to trade around $1.86 in the coming 90 days.

VYNE Therapeutics Stock Forecast 2025

Based on our predictive models, VYNE Therapeutics (VYNE) is expected to trade between $1.40 and $4.35 throughout 2026. This would result in an average price of $2.53, potentially offering investors a -91.14% return from current levels.

VYNE Therapeutics Inc. Monthly Forecast 2026–2027

July 2026

According to our latest forecast models, VYNE Therapeutics Inc. (VYNE) is positioned to show a strong performance in July 2026. The price is predicted to move between $1.59 and $1.85, settling at an average of $1.72. This could translate to a -93.98% loss.

August 2026

Based on current market signals, VYNE Therapeutics Inc. is projected to trend august 2026. We forecast a trading range from $1.46 to $2.10, with a likely average price of $1.74. Investors could expect a potential return of -93.91%.

September 2026

Our predictive algorithms indicate VYNE Therapeutics Inc. stock may see a shift in September 2026. The expected range spans $1.40–$2.30, with an average target of $1.82. This represents a cautious outlook and a possible loss of -93.63%.

October 2026

Analyzing established trends, VYNE Therapeutics Inc. looks set to move in October 2026. Projections place the stock between $1.77 and $2.37, averaging around $2.08. This suggests a -92.72% loss from current levels.

November 2026

Market indicators suggest VYNE Therapeutics Inc. could experience notable changes during November 2026. Prices could fluctuate within $2.08 to $4.35, with a midpoint forecast of $3.45. The stock might deliver a -87.92% loss.

December 2026

Forecasting for December 2026, models estimate that VYNE Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $2.91 and $4.28, averaging $3.70. This signals a cautious trajectory with potential returns around -87.04%.

January 2027

According to our latest forecast models, VYNE Therapeutics Inc. (VYNE) is positioned to show a strong performance in January 2027. The price is predicted to move between $2.26 and $4.67, settling at an average of $3.84. This could translate to a -86.55% loss.

February 2027

Based on current market signals, VYNE Therapeutics Inc. is projected to trend february 2027. We forecast a trading range from $2.09 to $4.78, with a likely average price of $3.82. Investors could expect a potential return of -86.62%.

March 2027

Our predictive algorithms indicate VYNE Therapeutics Inc. stock may see a shift in March 2027. The expected range spans $2.47–$4.90, with an average target of $4.28. This represents a cautious outlook and a possible loss of -85.01%.

April 2027

Analyzing established trends, VYNE Therapeutics Inc. looks set to move in April 2027. Projections place the stock between $2.28 and $5.32, averaging around $4.62. This suggests a -83.82% loss from current levels.

May 2027

Market indicators suggest VYNE Therapeutics Inc. could experience notable changes during May 2027. Prices could fluctuate within $2.08 to $6.58, with a midpoint forecast of $5.27. The stock might deliver a -81.55% loss.

June 2027

Forecasting for June 2027, models estimate that VYNE Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $1.06 and $5.36, averaging $3.66. This signals a cautious trajectory with potential returns around -87.18%.

July 2027

According to our latest forecast models, VYNE Therapeutics Inc. (VYNE) is positioned to show a strong performance in July 2027. The price is predicted to move between $1.03 and $5.19, settling at an average of $3.70. This could translate to a -87.04% loss.

VYNE's history of dividends and stock splits also plays a role in long-term investor confidence.